Evaluation of Different Culture Media for in Vitro Fertilization
1 other identifier
interventional
48
1 country
1
Brief Summary
Under in vivo conditions, human gametes and embryos are exposed to fluids in the fallopian tubes, where fertilization occurs, and in the uterus, the site of embryonic implantation. The composition of these microenvironments is extremely complex and diverse. On the other hand, infertile couples who need in vitro fertilization treatments have their gametes and embryos cultured for a few days in commercial culture media. The composition of the media used in assisted reproduction laboratories varies according to the manufacturer and culture strategy. It is already known that the exposure of embryos to different concentrations of nutrients can affect the effectiveness of in vitro fertilization treatments, such as the fertilization rate, embryonic development speed, implantation rate, gestation, abortion, newborn weight, among other factors. Although these aspects are much discussed in the literature, there is still no consensus regarding the choice of a specific culture medium. Thus, the present study aims to evaluate the influence of three commercial culture media on the fertilization rate and embryonic quality through a prospective randomized clinical trial using sibling oocytes from patients undergoing in vitro fertilization cycles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2022
CompletedFirst Submitted
Initial submission to the registry
December 22, 2022
CompletedFirst Posted
Study publicly available on registry
January 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedFebruary 28, 2024
February 1, 2024
5 months
December 22, 2022
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
day three good quality embryo rate
day three A/B embryos
64-67 hours
Secondary Outcomes (1)
fertilization
16-18 hours
Study Arms (3)
culture media of fabricant A
ACTIVE COMPARATORuse of culture media of fabricant A
culture media of fabricant B
ACTIVE COMPARATORuse of culture media of fabricant B
culture media of fabricant C
ACTIVE COMPARATORuse of culture media of fabricant C
Interventions
spliting of biological material and use of three culture media
Eligibility Criteria
You may qualify if:
- IVF/ICSI cycles;
- At least three oocytes retrieved;
- Consent term signed;
You may not qualify if:
- Less than three oocytes for fertilization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Insemine
Porto Alegre, Rio Grande do Sul, 91330001, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
João Sabino Cunha Filho, PhD
Hospital de Clínicas de Porto Alegre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2022
First Posted
January 9, 2023
Study Start
October 10, 2022
Primary Completion
March 1, 2023
Study Completion
March 31, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02